The analysis of unplanned readmissions after left ventricular assist device implantation as bridge-to-transplant
- 17 February 2020
- journal article
- research article
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 28 (1) , 55-62
Abstract
Background: In this study, we aimed to investigate frequency, patterns, etiologies, and costs of unplanned readmissions after left ventricular assist device implantation. Methods: Between April 2012 and September 2016, 99 unplanned readmissions of a total of 50 consecutive bridge-to-transplant patients (45 males, 5 females; mean age 46.9±10.3 years; range, 19 to 67 years) who were successfully discharged after left ventricular assist device implantation were retrospectively analyzed. Patient demographic data, hemodynamic measurements before implantation, and readmissions after discharge were recorded. Hospitalizations due to major problems which were unable to be managed in routine outpatient clinic were accepted as unplanned readmissions. Survival analysis was performed. Results: The readmission rate was 1.7 per year after discharge. Survival of patients who were readmitted within the first 90 days was found to be significantly lower than those without early readmission. The most common reasons of readmissions during follow-up were major infection (23.2%), neurological dysfunction (22.2%), cardiac causes (12.1%), bleeding (11.1%), and device malfunction (10.1%). Neurological dysfunctions (82,005 USD) and device malfunctions (73,300 USD) caused the highest economic burden. Conclusion: Among patients with a left ventricular assist device, hospital readmissions are common. Development of preventive strategies as well as effective treatment methods focused on longterm adverse events is critical to reduce the frequency and costs of hospital readmissions.Keywords
This publication has 21 references indexed in Scilit:
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- Readmissions Following Implantation of a Continuous-Flow Left Ventricular Assist DeviceJournal of Cardiac Surgery, 2016
- Future of Advanced Heart Failure and Mechanical Support Devices: Cardiology-Cardiovascular Surgery Consensus ReportTurk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 2016
- Hospital Readmissions After Continuous-Flow Left Ventricular Assist Device Implantation: Incidence, Causes, and Cost AnalysisThe Annals of Thoracic Surgery, 2015
- Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004–2011Open Heart, 2014
- Readmissions After Ventricular Assist Device: Etiologies, Patterns, and Days Out of HospitalThe Annals of Thoracic Surgery, 2013
- The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summaryThe Journal of Heart and Lung Transplantation, 2013
- Unplanned Hospital Readmissions After HeartMate II ImplantationJACC: Heart Failure, 2013
- Bleeding and Thrombosis in Patients With Continuous-Flow Ventricular Assist DevicesCirculation, 2012
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceNew England Journal of Medicine, 2009